| Catskill Mountain Psychology Pllc | |
|
159 Green St Kingston NY 12401-3736 | |
| (845) 331-2007 | |
| (845) 339-2382 |
| Full Name | Catskill Mountain Psychology Pllc |
|---|---|
| Speciality | Psychologist |
| Location | 159 Green St, Kingston, New York |
| Authorized Official Name and Position | Lawrence Dresdale (SOLE MEMBER) |
| Authorized Official Contact | 8453312007 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Catskill Mountain Psychology Pllc 50 Lauren Ct Kingston NY 12401-7207 Ph: (914) 388-9254 | Catskill Mountain Psychology Pllc 159 Green St Kingston NY 12401-3736 Ph: (845) 331-2007 |
| NPI Number | 1073992178 |
|---|---|
| Provider Enumeration Date | 05/21/2015 |
| Last Update Date | 09/21/2015 |
| Medicare PECOS PAC ID | 5193038792 |
|---|---|
| Medicare Enrollment ID | O20150724010593 |
News Archive
Ischemix today announced the initiation of patient accrual in a multi-center Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention (PCI) procedures. CMX-2043 is a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule.
A new, first-of-its-kind diabetes algorithm created to help achieve glycemic (blood sugar) control in type 2 patients was published online today in the September/October edition of Endocrine Practice.
Two dozen corporate leaders on Sunday signed a statement calling on 46 countries to lift restrictions on travelers who are living with HIV because the policies are discriminatory and bad for business, VOA's "Breaking News" blog reports.
Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073992178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 7948 (New York) | Primary |
| Provider Name | Lawrence E Dresdale |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1689791352 PECOS PAC ID: 7214124767 Enrollment ID: I20101209000640 |
News Archive
Ischemix today announced the initiation of patient accrual in a multi-center Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention (PCI) procedures. CMX-2043 is a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule.
A new, first-of-its-kind diabetes algorithm created to help achieve glycemic (blood sugar) control in type 2 patients was published online today in the September/October edition of Endocrine Practice.
Two dozen corporate leaders on Sunday signed a statement calling on 46 countries to lift restrictions on travelers who are living with HIV because the policies are discriminatory and bad for business, VOA's "Breaking News" blog reports.
Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
News Archive
Ischemix today announced the initiation of patient accrual in a multi-center Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention (PCI) procedures. CMX-2043 is a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule.
A new, first-of-its-kind diabetes algorithm created to help achieve glycemic (blood sugar) control in type 2 patients was published online today in the September/October edition of Endocrine Practice.
Two dozen corporate leaders on Sunday signed a statement calling on 46 countries to lift restrictions on travelers who are living with HIV because the policies are discriminatory and bad for business, VOA's "Breaking News" blog reports.
Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.
› Verified 4 days ago
County Of Ulster Ny Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 239 Golden Hill Ln, Kingston, NY 12401 Phone: 845-340-4000 Fax: 845-340-4094 | |
Hudson Valley Psychology Associates, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 159 Green St., Suite 1, Kingston, NY 12401 Phone: 845-339-2352 Fax: 845-339-2382 | |
Physician At Newburgh Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 396 Broadway, Kingston, NY 12401 Phone: 845-331-3131 | |
Jennica Laine-formisano Psyd Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 260 Kings Mall Ct # 331, Kingston, NY 12401 Phone: 845-489-3687 Fax: 845-332-6041 | |
Gateway Community Industries, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1 Amy Kay Pkwy, Kingston, NY 12401 Phone: 845-331-1261 Fax: 845-331-2112 | |
Specialty Care Center Of Kingston Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1 Foxhall Ave, Kingston, NY 12401 Phone: 845-338-8444 Fax: 845-338-2906 |